VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 116 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $505,000 | +10.3% | 40,000 | -20.0% | 0.02% | -12.0% |
| Q1 2020 | $458,000 | -66.3% | 50,000 | 0.0% | 0.02% | -60.3% |
| Q2 2019 | $1,361,000 | -62.6% | 50,000 | -73.7% | 0.06% | -62.5% |
| Q1 2019 | $3,635,000 | +103.6% | 189,927 | 0.0% | 0.17% | +95.3% |
| Q4 2018 | $1,785,000 | -47.6% | 189,927 | +5.6% | 0.09% | -44.2% |
| Q3 2018 | $3,404,000 | -0.4% | 179,927 | +2.9% | 0.15% | +14.1% |
| Q2 2018 | $3,418,000 | +4.0% | 174,927 | 0.0% | 0.14% | +1.5% |
| Q1 2018 | $3,287,000 | -25.3% | 174,927 | -34.0% | 0.13% | -21.3% |
| Q4 2017 | $4,398,000 | +29.5% | 264,927 | +60.6% | 0.17% | +32.0% |
| Q3 2017 | $3,396,000 | +110.5% | 164,927 | -8.4% | 0.13% | +120.7% |
| Q2 2017 | $1,613,000 | +10.8% | 180,000 | +63.6% | 0.06% | +18.4% |
| Q1 2017 | $1,456,000 | +14.3% | 110,000 | +10.0% | 0.05% | +4.3% |
| Q4 2016 | $1,274,000 | – | 100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |